Brief: Sartorius Stedim Biotech Signs MoU With Sensible Biotechnologies On Cell-Based mRNA Production
July 9 (Reuters) - Sartorius Stedim Biotech SA STDM.PA: SIGNS MOU WITH SENSIBLE BIOTECHNOLOGIES TO ADVANCE CELL-BASED MRNA PRODUCTION COLLABORATION AIMS TO ENABLE CLINICAL-GRADE PRODUCTION OF CELL-BASED MRNA BY 2026 Source text: here Further company coverage: STDM.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))